A Clinical Study of Aprotinin on Perioperative Blood Conservation in Patients Undergoing Orthotopic Liver Transplantation
李勇,崔苏扬,靳艳卿,李榕,周路阳,顾小萍
DOI: https://doi.org/10.3760/cma.j.issn.1673-4904.2009.33.001
2009-01-01
Abstract:Objective To investigate the effect of aprotinin on perioperative blood conservation in patients undergoing orthotopic liver transplantation (OLT). Methods Forty patients with end-stage liver diseases, undergoing OLT were randomly divided into two groups: aprotinin group received intravenous infusion aprotinin continuously during the whole operation (group A, 20 cases)and control group received the same amount of normal saline instead of aprotinin (group C, 20 cases). Internal jugular vein blood sampleswere collected to measure the coagulation variables including prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), fibrinogen (FIB), and R value of thrombelastography (TEG) on time points:before skin incision (T1), 5 min in anhepafic phase (T2), 5 min, 30 min and 120 min after reperfusion phase (T3, T4, T5). The volume of total blood loss, red blood cell, blood plasma, platelet and liquid transfusion during operation were observed. Results The volume of total blood loss during operation, blood loss recovery(washed by cell saver)during operation, red blood cell (washed by cell saver) and blood plasma, albumin, colloid liquid transfusion perioperation was (3708 ± 1910),(1321 + 488),(2121 ± 785), (2568 ± 904), (200 ± 63), (3830 ± 897) ml respectively in group A. The matched pair analysis volume was (5676 ± 2241), (2034 ± 734), (2697 ± 978), (3725 ± 1374), (259 ± 83), (5065 ± 1505) ml respectively in group C. Compared with group C, these volume in group A were lower (P < 0.01 or < 0.05). There was no significant difference in each item of coagulation function at T1 time point between the two groups. Each item of coagulation function (PT, APTT, TT and R value of TEG) at T2-T5 time point in group A was better than that in group C (P < 0.05 or < 0.01). Conclusion Aprotinin used in end-stage hver diseases patients during OLT can ameliorate coagulation function, decrease the blood loss perioperation, reduce the amount of homologous blood and blood plasma substitute transfusion, it has a good effect on perioperative blood conservation.